NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category (Descending) | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
52125-0569-10 | 52125-0569 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Oct. 10, 2014 | Oct. 10, 2014 | No Longer Used |
52125-0569-14 | 52125-0569 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Oct. 28, 2014 | April 8, 2017 | No Longer Used |
52125-0569-38 | 52125-0569 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Feb. 27, 2013 | May 8, 2016 | No Longer Used |
52125-0569-52 | 52125-0569 | Ondansetron | Ondansetron | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Aug. 8, 2013 | Aug. 8, 2014 | No Longer Used |
47335-0581-40 | 47335-0581 | Amifostine | Amifostine | 50.0 mg/mL | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Intravenous | March 14, 2008 | July 31, 2013 | No Longer Used |
47335-0581-42 | 47335-0581 | Amifostine | Amifostine | 50.0 mg/mL | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Intravenous | March 14, 2008 | July 31, 2013 | No Longer Used |
58178-0017-01 | 58178-0017 | Amifostine | Ethyol | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Dec. 8, 1995 | April 30, 2012 | No Longer Used | ||
58178-0017-03 | 58178-0017 | Amifostine | Ethyol | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Dec. 8, 1995 | April 30, 2012 | No Longer Used | ||
54092-0064-01 | 54092-0064 | Anagrelide | Agrylin | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | March 14, 1997 | March 31, 2008 | No Longer Used | |
54868-5385-00 | 54868-5385 | Anagrelide | Anagrelide | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | Aug. 15, 2005 | June 30, 2011 | No Longer Used | |
54868-5385-01 | 54868-5385 | Anagrelide | Anagrelide | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | Aug. 15, 2005 | June 30, 2011 | No Longer Used | |
00185-0155-01 | 00185-0155 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | April 18, 2005 | March 31, 2012 | No Longer Used | |
00185-0155-05 | 00185-0155 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | April 18, 2005 | March 31, 2012 | No Longer Used | |
00185-0156-01 | 00185-0156 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | April 18, 2005 | March 31, 2012 | No Longer Used | |
00185-0156-05 | 00185-0156 | Anagrelide Hydrochloride | Anagrelide Hydrochloride | Ancillary Therapy | Platelet-Reducing Agent | PDE-3 Inhibitor | Oral | April 18, 2005 | March 31, 2012 | No Longer Used | |
00006-3862-03 | 00006-3862 | Aprepitant | Emend | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | March 26, 2003 | In Use | |||
00006-3862-13 | 00006-3862 | Aprepitant | Emend | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | March 26, 2003 | In Use | |||
00781-2321-06 | 00781-2321 | Aprepitant | Aprepitant | 40.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2321-51 | 00781-2321 | Aprepitant | Aprepitant | 40.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2322-46 | 00781-2322 | Aprepitant | Aprepitant | 80.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2322-68 | 00781-2322 | Aprepitant | Aprepitant | 80.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-2323-68 | 00781-2323 | Aprepitant | Aprepitant | 125.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Dec. 27, 2016 | In Use | |
00781-4063-36 | 00781-4063 | Aprepitant | Aprepitant | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Dec. 27, 2016 | In Use | |||
54868-5325-00 | 54868-5325 | Aprepitant | Emend | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | June 24, 2005 | In Use | |||
00078-0110-22 | 00078-0110 | Cyclosporine | Sandimmune | 100.0 mg/mL | Ancillary Therapy | Immunomodulator | Calcineurin Inhibitor | Oral | Nov. 14, 1983 | In Use |
Found 10,000 results in 9 milliseconds — Export these results